ACP 2.0 software empowers laboratories to implement push‑button, end‑to‑end automated NMR workflows across the entire product lifecycle, from early research through development and manufacturing. It redefines how analytical and testing facilities can leverage NMR technology by enabling harmonized workflows, significantly improving operational efficiency, and reducing costs through standardized, GMP‑ready, operator‑independent analysis, seamlessly connecting sample to final reporting.
ACP 2.0 enables fully automated end‑to‑end qNMR workflows, from acquisition, processing, identification, quantification, reporting, to result submission. With advanced signal modelling and fitting, high‑performance baseline handling, pass/fail evaluation, a custom calculation tool, and customizable reports, ACP 2.0 supports analytical challenges in industrial, biopharma and academia environments. It facilitates methods harmonization and transfer, allowing experts to develop robust workflows and deploy them to non‑expert environments. This webinar highlights core features, workflows, and use cases demonstrating how ACP 2.0 simplifies analysis and improves efficiency in quantitative NMR regardless of the sample’s complexity.
Wednesday, May 20 2026
5 PM CEST
In this webinar you will learn about the features and benefits of ACP2.0 software and how the new high-performance fitting capabilities enable the automation of any quantitative NMR workflow from simple to highly complex in the chemical & biopharma industry as well as in academic environments focusing on metabolomic research.
Automated End to End Workflow
Standardized Decision Making
High Throughput, Compliant Analysis
Precision Through High Performance Algorithms
Dr. Markus Hecht
Solution Portfolio Manager BPA, Bruker BioSpin
Markus Hecht holds a doctoral degree in chemistry from the Julius-Maximilians-University of Würzburg. He later joined BASF and Sun Chemical to lead research laboratories in the development of new products and manufacturing processes in the field of organic pigments. At Bruker, Markus is responsible for providing value-adding solutions to customers in the chemical industry and in commercial & governmental testing laboratories.
Dr. Claire Cannet
Senior Solutions Product Manager for Metabolomics at Bruker BioSpin.
Claire holds a Ph.D. in pathobiochemistry from Ruprecht‑Karls‑University Heidelberg and has over 15 years of experience spanning clinical research, translational metabolomics, and NMR metabolomics applications. She collaborates closely with academic and clinical research partners to advance NMR solutions for metabolomics and translational research.
Dr. Valentin Poirier
Senior Solution Developer Biopharma & Applied Division, Bruker BioSpinValentin joined Bruker BioSpin in 2024 as a Solution Product Manager in the BioPharma team. In this role, he collaborates with the pharmaceutical industry to advance Nuclear Magnetic Resonance solutions tailored to drug development and manufacturing, with a strong emphasis on quality control and compliance. A trained chemist, he entered the pharmaceutical industry after completing his Ph.D. Over the past decade, he has managed analytical platforms at CROs (Albhades and Evotec), focusing on NMR and Mass Spectrometry as modern tools for analytical sciences and regulated applications (GMP/GLP). As a technical expert, he has contributed to the development of dozens of analytical projects for pharmaceutical applications and quality control, with a customer-centric and problem-solving approach.